Growth and expansion Allergan (Actavis) has a history of facility expansion in the US and ongoing product launches in aesthetics and surgical adhesives, suggesting ongoing demand for manufacturing capacity, regulatory-compliant sourcing, and supply chain amplification opportunities.

Aesthetics leadership Strong focus on aesthetics products such as Juvederm Volux and Future of Aesthetics insights indicate ongoing market demand for high-margin injectable and filler solutions, presenting upsell potential for related devices, materials, and training services.

Clinical and regulatory Past recalls and FDA interactions around textured breast implants highlight the importance of quality assurance, sterilization, and post-market surveillance services that can be offered as risk-mitigating solutions for distributors and clinics.

Strategic partnerships Recent ecosystem engagement with web development and large-scale cloud tech usage signals openness to collaborate on digital platforms, data analytics, and e-commerce enablement for pharma distribution and patient engagement channels.

Global footprint Irish base with a transatlantic manufacturing and product launch history positions Allergan to explore regional supply deals, contract manufacturing, and cross-border distribution partnerships in North America and Europe.